Role of FNAC, fluid specimens, and cell blocks for cytological diagnosis of lung cancer in the present era
- PMID: 26811567
- PMCID: PMC4707781
- DOI: 10.4103/0970-9371.171219
Role of FNAC, fluid specimens, and cell blocks for cytological diagnosis of lung cancer in the present era
Abstract
Cytoblocks prepared from residual tissue fluids and fine-needle aspirations can be useful adjuncts to smears for establishing a more definitive cytopathologic diagnosis. These paraffin embedded cytoblocks have been popular since these can be handled like any other histologic specimen. Rapid on-site evaluation (ROSE) can help in attaining adequate material in the cytoblock, which is a major concern to the cytopathologists. Ancillary studies can be done using cytoblocks including IHC and various molecular techniques. The opportunities for cytopathologists to influence therapy, and uncover strategies in the complex field of lung cancer are exciting and limitless especially in the presence of an adequate cytoblock.
Keywords: Cytology; epidermal growth factor receptor (EGFR) mutations; fine-needle aspiration cytology (FNAC); immunochemistry; lung cancer.
Figures


Similar articles
-
Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.J BUON. 2015 Jan-Feb;20(1):142-5. J BUON. 2015. PMID: 25778309
-
Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.Cancer Cytopathol. 2013 Jul;121(7):361-9. doi: 10.1002/cncy.21273. Epub 2013 Jan 30. Cancer Cytopathol. 2013. PMID: 23364874
-
Ultrasonography Guided Fine Needle Aspiration Cytology with Preparation of Cell Blocks in the Diagnosis of Intra- Abdominal Masses.J Clin Diagn Res. 2015 Dec;9(12):EC08-12. doi: 10.7860/JCDR/2015/16490.6869. Epub 2015 Dec 1. J Clin Diagn Res. 2015. PMID: 26816896 Free PMC article.
-
Preanalytic specimen triage: Smears, cell blocks, cytospin preparations, transport media, and cytobanking.Cancer Cytopathol. 2017 Jun;125(S6):455-464. doi: 10.1002/cncy.21850. Cancer Cytopathol. 2017. PMID: 28609003 Review.
-
[Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].Acta Med Croatica. 2008 Oct;62(4):391-401. Acta Med Croatica. 2008. PMID: 19205416 Review. Croatian.
Cited by
-
Immunocytochemical Evaluation of TTF-1, Napsin-A, and p-63 for Subtyping of Non-Small Cell Lung Carcinoma and Clinicopathological Correlation.J Cytol. 2022 Oct-Dec;39(4):180-187. doi: 10.4103/joc.joc_5_22. Epub 2022 Nov 14. J Cytol. 2022. PMID: 36605876 Free PMC article.
-
Role of cell block in cytopathologic evaluation of image-guided fine needle aspiration cytology.J Cytol. 2017 Jul-Sep;34(3):133-138. doi: 10.4103/JOC.JOC_82_15. J Cytol. 2017. PMID: 28701825 Free PMC article.
References
-
- Noronha V, Dikshit R, Raut N, Joshi A, Pramesh CS, George K, et al. Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience. Indian J Cancer. 2012;49:74–81. - PubMed
-
- Ciuleanu T, Brodowicz T, Zielinski C, Kim JH, Krzakowski M, Laack E, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomized, double-blind, phase 3 study. Lancet. 2009;374:1432–40. - PubMed
-
- Scagliotti G, Hanna N, Fossella F, Sugarman K, Blatter J, Peterson P, et al. The differential efficacy of pemetrexed according to NSCLC histology: A review of two phase III studies. Oncologist. 2009;14:253–63. - PubMed
-
- Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small- cell lung cancer. J Clin Oncol. 2008;26:3543–51. - PubMed
-
- Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184–91. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous